Site‐directed mutagenesis of the chemokine receptor CXCR6 suggests a novel paradigm for interactions with the ligand CXCL16
Authors:
Open Access
- 24 July 2008
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 38 (8) , 2337-2350
Abstract
Chemokine receptor CXCR6 mediates the chemotaxis and adhesion of leukocytes to soluble and membrane‐anchored forms of CXCL16, and is an HIV‐1 co‐receptor. Here, we describe the effects of mutation of acidic extracellular CXCR6 residues on receptor function. Although most CXCR6 mutants examined were expressed at levels similar to wild‐type (WT) CXCR6, an N‐terminal E3Q mutant was poorly expressed, which may explain previously reported protective effects of a similar single nucleotide polymorphism, with respect to late‐stage HIV‐1 infection. In contrast to several other chemokine receptors, mutation of the CXCR6 N terminus and inhibition of post‐translational modifications of this region were without effect on receptor function. Likewise, N‐terminal extension of CXCL16 resulted in a protein with decent potency and efficacy in chemotaxis and not, as anticipated, a CXCR6 antagonist. D176N and E274Q CXCR6 mutants were unable to interact with soluble CXCL16, suggesting a critical role for D176 and E274 in ligand binding. Intriguingly, although unable to interact with soluble CXCL16, the E274Q mutant could promote robust adhesion to membrane‐anchored CXCL16, suggesting that soluble and membrane‐bound forms of CXCL16 possess distinct conformations. Collectively, our data suggest a novel paradigm for the CXCR6:CXCL16 interaction, a finding which may impact the discovery of small‐molecule antagonists of CXCR6.Keywords
This publication has 40 references indexed in Scilit:
- Small Molecule Receptor Agonists and Antagonists of CCR3 Provide Insight into Mechanisms of Chemokine Receptor ActivationJournal of Biological Chemistry, 2007
- Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by α- and γ-secretasesBiochemical and Biophysical Research Communications, 2007
- CXCR3 Requires Tyrosine Sulfation for Ligand Binding and a Second Extracellular Loop Arginine Residue for Ligand-Induced ChemotaxisMolecular and Cellular Biology, 2006
- Chemokines Generally Exhibit Scavenger Receptor Activity through Their Receptor-binding DomainJournal of Biological Chemistry, 2004
- Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cellsJournal of Leukocyte Biology, 2003
- Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi‐step model of ligand binding and receptor activationEuropean Journal of Immunology, 2003
- Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African AmericansGenes & Immunity, 2003
- Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on MacrophagesJournal of Biological Chemistry, 2000
- Unique Role of the Chemokine Domain of Fractalkine in Cell CaptureJournal of Biological Chemistry, 2000
- The N-terminal Extracellular Segments of the Chemokine Receptors CCR1 and CCR3 Are Determinants for MIP-1α and Eotaxin Binding, Respectively, but a Second Domain Is Essential for Efficient Receptor ActivationJournal of Biological Chemistry, 1998